By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
AdkhabarAdkhabarAdkhabar
Notification Show More
Font ResizerAa
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Reading: Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
Share
Font ResizerAa
AdkhabarAdkhabar
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Search
  • Home
  • Automobile
  • Entertainment
  • Esports
  • Food
  • Health
  • Life Style
  • News
  • Technology
  • Travel
Follow US
Adkhabar > Blog > Technology > Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration
Technology

Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration

GlobeNews Wire
Last updated: 12/09/2025 8:36 AM
GlobeNews Wire
Published: 12/09/2025
Share
SHARE

SINGAPORE, Sept. 12, 2025 (GLOBE NEWSWIRE) — Armstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories across 7 countries in Asia, has signed a Memorandum of Understanding (MOU) with Checkmate Capital Group, LLC (“Checkmate Capital”), a U.S.-based investment and advisory firm active in the Asia-Pacific and North American regions, focused on cross-border transactions in the life sciences, medical technology, and other industries.

The MOU marks the beginning of a formal relationship between the two companies, following Armstrong’s successful collaboration with NeuroSigma, Inc (“NeuroSigma”), a Los Angeles-based bioelectronics company and a portfolio company of Checkmate Capital. Armstrong has supported NeuroSigma in building efficient and scalable supply chains for its products.

This agreement will serve as a platform for Armstrong and Checkmate Capital to explore additional areas of collaboration, particularly in the evolving medical device industry.

Ms. Phyllis Ong, Group CEO of Armstrong Asia, said: “This MOU reflects our ongoing efforts to expand Armstrong’s contribution to the medical device industry by building strategic relationships. Our work with NeuroSigma demonstrated the value of combining advanced engineering capabilities with responsive supply chain solutions, and we are pleased to take this next step with Checkmate Capital Group.”

Mr. C. Thomas Paschall, CEO of Checkmate Capital Group, commented: “We are pleased to formalise our relationship with Armstrong Asia. Armstrong’s support of NeuroSigma’s supply chain needs has demonstrated the strong capabilities and reliability they bring to the table. We look forward to exploring additional opportunities to work together in the future.”

This partnership supports Armstrong’s long-term vision of becoming a world-class manufacturing gateway that enables smarter, safer, and greener innovation through trusted partnerships.

About Armstrong Industrial Corporation

Armstrong Industrial Corporation is Asia’s leading manufacturer of flexible material solutions with 16 factories across Malaysia, Thailand, Indonesia, Vietnam, the Philippines and China. Founded and headquartered in Singapore since 1974, Armstrong combines superior engineering solutioning with a proprietary database of over 6000 materials and 13 precision engineering process technologies. Its strong commitment to quality and innovation has made it a leader in Noise, Vibration, Heat & Safety Management Solutions. With its strategic presence, a global network, and one-stop integrated capabilities, Armstrong delivers innovation and quality across diverse industries like automotive, consumer electronics, medical, hard disk drive and industrial manufacturing. To learn more, visit https://armstrongasia.com/

About Checkmate Capital Group

Headquartered in Pasadena, California, Checkmate Capital is a cross-Pacific strategic advisory and investment group managing internal family office assets with a global commercial and industry-specific network. Checkmate Capital’s primary areas of investment are biotechnology, life sciences, medical technology, agriculture technology, and energy technology. The Checkmate Capital team provides seasoned expertise in our focused industries, leveraging an international group of strategic partners, business talent, and resources. Checkmate advises numerous life sciences companies – both publicly traded and privately held – in North America and Asia in connection with commercial operations, business growth, strategic relationships and intellectual property licensing. For more information, visit https://www.checkmatecapital.net/.

Media contact: Tan Lee San leesan.tan@armstrongasia.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e5db96dd-259e-4386-a513-2a8b258c5df8

UK-certified ALL4 Mining launches the best free cloud mining for BTC, DOGE, XRP and other popular currency enthusiasts
Bain & Company appoints Shintaro Okuno as new Regional Managing Partner for Asia-Pacific
Hexaware Appoints Eravi Gopan to Lead High Tech, Products, and Platforms Globally
/C O R R E C T I O N — IFPA/
Revolution Medicines Awarded Voucher for Daraxonrasib (RMC-6236) Under FDA Commissioner’s National Priority Voucher Pilot Program
TAGGED:armstrongasiacapitalcheckmatecollaborationexploregroupmounewssignsstrategicwith
Share This Article
Facebook Email Print
- Advertisement -

Follow US

Find US on Social Medias
FacebookLike
XFollow
YoutubeSubscribe

Weekly Newsletter

Subscribe to our newsletter to get our newest articles instantly!
Popular News
Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor
Health

Aptose Biosciences Announces Results of Reconvened Annual and Special Shareholders Meeting and Appointment of Ernst & Young LLP as New Auditor

GlobeNews Wire
GlobeNews Wire
23/08/2025
XCMG Opens 7th XCMG International Customer Festival, Strengthening Collaboration with Global Partners
WSPN Brings Next-Generation Stablecoin Innovation to Conviction 2025 Vietnam
Kolmar Korea Presents “K-Beauty Success Roadmap” in Amazon Beauty in Seoul
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
- Advertisement -
- Advertisement -
- Advertisement -

Categories

  • Automobile
  • Entertainment
  • E-Sports
  • Food
  • Health
  • Technology
  • LifeStyle
  • Travel

About Us

Through our news networks, we raise millions of users' awareness. We are among the world's most reputable news networks.
Quick Link
Top Categories
  • Entertainment

Subscribe US

Subscribe to our newsletter to get our newest articles instantly!

AdkhabarAdkhabar
Copyright © 2021 - 2025 AdKhabar. All Rights Reserved. POWERED BY Life Care News.
Join Us!
Subscribe to our newsletter and never miss our latest news, podcasts etc..
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?